NUFARM LIMITED (NUF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NUF

NUF - NUFARM LIMITED

FNArena Sector : Agriculture
Year End: September
GICS Industry Group : Materials
Debt/EBITDA: 3.08
Index: ASX300 | ALL-ORDS

Nufarm is an Australian agricultural chemicals company with manufacturing and marketing operations in Australia, Asia, Europe and North America. First established in 1956, it became a listed company in 1988.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$3.06

19 Nov
2026

-0.220

OPEN

$3.26

-6.71%

HIGH

$3.27

7,799,776

LOW

$2.86

TARGET
$3.648

+0.06 change from previous day

19.2% upside
OTHER COMPANIES IN THE SAME SECTOR
AAC . AMN . APC . CBO . ELD . GNC . HFR . RIC . SGLLV . SHV . TFL .
FNARENA'S MARKET CONSENSUS FORECASTS
NUF: 1
Title FY25
Actual
FY26
Actual
FY27
Forecast
FY28
Forecast
EPS (cps) xxx - 25.8 15.8 xxx
DPS (cps) xxx 0.0 2.4 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 18.2 xxx
Dividend Yield xxx N/A 0.8% xxx
Div Pay Ratio(%) xxx N/A 15.2% xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

$ 

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 29/05 - (franking ex-div 4c)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx-25.8
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx3,210.8 M
Book Value Per Share xxxxxxxxxxxxxxx429.1
Net Operating Cash Flow xxxxxxxxxxxxxxx236.0 M
Net Profit Margin xxxxxxxxxxxxxxx-2.48 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx-5.66 %
Return on Invested Capital xxxxxxxxxxxxxxx-2.65 %
Return on Assets xxxxxxxxxxxxxxx-1.82 %
Return on Equity xxxxxxxxxxxxxxx-3.97 %
Return on Total Capital xxxxxxxxxxxxxxx5.16 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx137.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx203 M
Long Term Debt xxxxxxxxxxxxxxx968 M
Total Debt xxxxxxxxxxxxxxx1,171 M
Goodwill - Gross xxxxxxxxxxxxxxx387 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx423 M
Price To Book Value xxxxxxxxxxxxxxx0.76

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx162.4 M
Capex % of Sales xxxxxxxxxxxxxxx5.06 %
Cost of Goods Sold xxxxxxxxxxxxxxx2,222 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx822 M
Research & Development xxxxxxxxxxxxxxx68 M
Investments - Total xxxxxxxxxxxxxxx70 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.6

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

20/11/2026

3

Neutral

$3.40

11.11%

Following FY26 results for Nufarm, Citi leaves its earnings forecasts largely unchanged but lowers its FY27–FY28 profit (NPAT) estimates by -11% to -17% to reflect implied earnings guidance.

The broker raises its target price by 10c to $3.40 and retains a Neutral rating.

First Take: Citi observes Nufarm's FY26 EBITDA rose 25% y/y and was in line with consensus and guidance, while revenue declined -7%.

Crop Protection EBITDA missed consensus by around -3%, offset by Seed Technologies, which beat by 14%, assisted by strong canola seed sales and improved Omega-3 oil pricing.

Notably, regional performance was mixed, with APAC EBITDA beating consensus by 7% despite a -4% revenue miss. North American 2H26 EBITDA declined -9%, while European margins contracted by -310bp due to manufacturing disruptions.

Management's FY27 guidance implies mid-teens EBITDA growth in Seed Technologies and mid-single-digit growth in Crop Protection.

The broker's EBIT forecast of $194m is around -2% below consensus of $199m, although implied NPAT of $40m exceeds consensus of $24m.

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

NUF STOCK CHART